Taylor-Fishwick Jonathan, Duarte Vivian, Olson Kaitlin E, Jacobsen Roni M, Kay Joseph, Khanna Amber, Downs Emily A, Jaggers James, SooHoo Megan
Internal Medicine-Pediatrics Residency, University of Colorado School of Medicine, 12631 East 17th Avenue 8601, Aurora, CO, 80045, USA.
University of Colorado School of Medicine, Aurora, USA.
Pediatr Cardiol. 2025 May 7. doi: 10.1007/s00246-025-03891-9.
The PErioperative ACHd (PEACH) score is a mortality risk assessment tool for adult congenital heart disease (ACHD) patients created to address the unique surgical risks in this population. Evaluation of the PEACH score's validity in a US cohort is needed. This paper sought to assess the PEACH score's performance in ACHD patients undergoing cardiac surgery. Secondary objectives included comparison of the PEACH score to other surgical risk assessment tools, score association with post-operative morbidities, and exploration of additional variables that may improve the score. A retrospective cohort study was conducted in ACHD patients who underwent cardiac surgery at the University of Colorado Hospitals between 2010 and 2022. Patients were identified by the institutional STS database. Components of the PEACH score and additional risk factors were evaluated by univariable analysis and subsequent logistic regression. A ROC curve compared the PEACH score to existing risk models. 516 patients were included with a median age of 30 years and 51% male. There were 9 (1.7%) deaths. Zero of 240 low-risk patients died, 6 of 229 intermediate-risk patients died (2.6%), and 3 of 41 high-risk patients died (7.3%). Model comparison revealed PEACH score AUC 0.832, ACHS score AUC 0.869, and STAT AUC 0.769. The addition of platelet level (< 150,000) improved the PEACH score (AUC 0.843, 95% CI 0.747-0.939). The PEACH score provided strong predictive ability for perioperative mortality in this ACHD cardiac surgery cohort and was associated with increased morbidity. The addition of platelet level to the score may improve its accuracy.
围手术期先天性心脏病(PEACH)评分是一种针对成人先天性心脏病(ACHD)患者的死亡风险评估工具,旨在应对该人群独特的手术风险。需要评估PEACH评分在美国队列中的有效性。本文旨在评估PEACH评分在接受心脏手术的ACHD患者中的表现。次要目标包括将PEACH评分与其他手术风险评估工具进行比较、评分与术后发病率的关联,以及探索可能改善该评分的其他变量。对2010年至2022年在科罗拉多大学医院接受心脏手术的ACHD患者进行了一项回顾性队列研究。通过机构STS数据库识别患者。通过单变量分析和随后的逻辑回归评估PEACH评分的组成部分和其他风险因素。ROC曲线将PEACH评分与现有风险模型进行了比较。纳入了516例患者,中位年龄为30岁,男性占51%。有9例(1.7%)死亡。240例低风险患者中无死亡,229例中度风险患者中有6例死亡(2.6%),41例高风险患者中有3例死亡(7.3%)。模型比较显示,PEACH评分的AUC为0.832,ACHS评分的AUC为0.869,STAT评分的AUC为0.769。添加血小板水平(<150,000)可改善PEACH评分(AUC为0.843,95%CI为0.747 - 0.939)。PEACH评分对该ACHD心脏手术队列的围手术期死亡率具有很强的预测能力,并且与发病率增加相关。在评分中添加血小板水平可能会提高其准确性。